Sharjah Achieves Historic WHO Age-Friendly Status
SHARJAH, UAE, Jan. 19, 2026 /PRNewswire/ -- The Emirate of Sharjah, UAE, has reached a new global milestone by obtaining "Advanced Affiliate" membership in the World Health Organization's (WHO) Global Network for Age-Friendly Cities and Communities. This makes Sharjah the first Arab city to achieve this prestigious status. This achievement underscores the emirate's deep commitment to enhancing the well-being...
D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications: D3S‑003 — a KRAS G12D inhibitor — enabling the start of a Phase 1 first‑in‑human...
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that through its wholly-owned subsidiary, it has exercised its warrant to acquire the common stock in Spruce Biosciences, Inc. (Nasdaq:...
A Smarter New Year’s Resolution: Investing in Eye Comfort for Screen Heavy Workdays
SYDNEY, Jan. 19, 2026 /PRNewswire/ -- As the new year begins, many Australians are setting resolutions focused on health, balance and long-term wellbeing. While fitness goals and productivity upgrades often dominate the conversation, eye comfort during extended screen use is frequently overlooked. With work, communication and entertainment increasingly centred around screens, visual fatigue has become a common challenge, particularly...
WuXi AppTec Receives Double “A” Rating from CDP for Climate Change and Water Security Leadership
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the "A List" for leadership in corporate transparency and performance across both Climate Change and Water Security by CDP (Carbon Disclosure Project). This recognition, which represents CDP's highest rating in each category,...
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of the Prostate Avoidance Stratification Study), a Phase 3 trial to evaluate the use of Telix's commercial PSMA-PET imaging...
NUH INAUGURATES NEW CENTRE TO ADVANCE PREDICTIVE AND ACCESSIBLE CARE FOR DIGESTIVE HEALTH
The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver...
POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies
GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic collaboration with leading domestic pharmaceutical companies to accelerate the growth of its internet hospital business. The Company expects these partnerships to become a core component of...
Henlius Showcases “Globalisation 2.0” Strategy and Mid-to-Long-Term Innovation Blueprint at JPM 2026
SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- The 44th J.P.Morgan Healthcare Conference (JPMHC) was successfully held in San Francisco, the United States, from January 12 to 15. As one of the most influential annual events in the global healthcare sector, JPM serves as a key platform for the capital markets and industry leaders to observe emerging trends in pharmaceutical innovation...
Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market
Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansion Builds an integrated global commercialization platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide Delivers Zylox-Tonbridge's manufacturing and operational synergies across Germany and China Fully unlocks Zylox-Tonbridge's high-efficiency R&D capabilities HANGZHOU, China and BERLIN, Jan. 16, 2026 /PRNewswire/ -- Zylox-Tonbridge (HKEX:2190), a Hong Kong-listed medical technology company focused...
